... epidemiology ofcancer pain and of its treatments,the quality of analgesic-drug therapy and the effectiveness of alternative analgesic strategies in a large,prospective, unselected cohort ofcancerpatients ... epidemiology of cancer pain and of its treatments, the quality of analge-sic-drug therapy and the effect of alternative analgesicstrategies in a large, prospective, unselected cohort of can-cer patients ... thetreatment (for example, the choice of morphine in eligible patients) , eventually the comparison of outcomes (for example, pian intensity) by matching or stratifing patients according to the value of...
... studied 30 patients treatedwith CMS for at least 48 h [27]. Nephrotoxicity wasobserved in ten (33%) patients (Injury: 3 patients; Fail-ure: 5 patients; End-stage: 2 patients) . Patients whodeveloped ... receivedintravenous CMS for at least 3 days [20]. Overall, 30(45%) patients exhibited criteria for nephrotoxicity atthe time of peak creatinine level (Risk: 13 patients; Injury: 10 patients; Failure: 7 patients) . ... patients) . In 21% of the patients, CMS was stopped because of nephrotoxicity.Spapen et al. Annals of Intensive Care 2011, 1:14http://www.annalsofintensivecare.com/content/1/1/14Page 3 of 7 Table...
... study documents the impact of skin sideeffects onquality of life of advanced colon cancerpatients treatedwith EGFR inhibitors. Among the evaluated scales con-sidered by Skindex29 questionnaire, ... where not only onco-logical patients are considered [8,11,14,15]. Respect toother conditions, the impact of skin sideeffects on colon cancer patients is relevant for all the three scales consid-ered. ... Board of thehospital, and all patients were provided with a writteninformed consent before entering the study. Eligible patients were Italian speaking older than 18 years of age.All patients...
... Validation of the Euro-pean Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breastcancer patients. Eur J Cancer 1998, ... in breast cancer – taking stock. Journal of the National Cancer Institute2003, 95(4):263-281.46. Montazeri A: Health-related quality of life in breast cancer patients: a bibliographic review of ... interventions for breast cancer survivors [9-18]. Given the high prevalence of breastcancer and budget constraints in health care, it isalso important to understand the impact of alternativestrategies...
... more severe sideeffects [22]. One of the reasons could be ascribed to the composition of the formulation and the poor control of the drug release rate. Therefore, the development of compatible ... nanocapsule form. This observation was consistent with a previous report [48] related to a nanoparticulate form of another anticancer drug (doxorubicin) tested on a different breastcancer cell ... surface tension of drug and excipients, respectively. 12 References [1] Herbst RS, Khuri FR: Mode of action of docetaxel - a basis for combination with novel anticancer agents. Cancer Treat...
... the for- mer, the most used in Europe forbreastcancer are theEuropean Organization for Research and Treatment of Cancer Core Cancer Quality Life Questionnaire(EORTC QLQ-C30) and its breast- cancer- speci ... methodological quality of studies was assessed.Results: Spain ranked midway in the European Union in terms of the number of studies conducted on the HRQL of breastcancer patients. Of the total of 133 papers ... EuropeanOrganization for Research and Treatment of Cancer; EORTC QLQ-BR23:European Organization for Research and Treatment ofCancer Quality LifeQuestionnaire BreastCancer Specific Module;...
... J Cancer 1991, 64:1133-1138.12. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 539 have been followed up for 15 years. Br J Cancer ... JL: Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987, 56:489-492.14. Lonn U, Lonn S, Nilsson B, Stenkvist B: Breast cancer: prognosticsignificance of c-erb-B2 and ... Serum levels of IL-6 correlates well with the extent of tumor invasion, LN metastasis, distantmetastasis and TNM staging thus enveloping all aspects ofbreast cancer. Introduction Breast cancer is...
... of immunocytochemically localizedestrogen receptors in human breast cancer. Cancer Res 1990,5012:3545-3550.9. British Breast Group: Assessment of response to treatment in advanced breast cancer. ... 9:101http://www.wjso.com/content/9/1/101Page 2 of 4 RESEARC H Open AccessClinical relevance of “withdrawal therapy” as aform of hormonal manipulation forbreast cancer Amit Agrawal*, John FR Robertson ... provide additional line of therapy. It should be considered as part of the sequencing of endocrinetherapy.BackgroundEstrogen receptor (ER) positive breast cancers after aperiod of response to anti-estrogens...
... type of organization for the treatment ofbreast cancer. Thischange will be driven not much from “ mandatory”requirements, but by the willingness of more sophisti-cated breastcancerpatients ... R,Taylor C, Wang Y: Early BreastCancer Trialists’ Collaborative Group(EBCTCG). Effectsof radiotherapy and of differences in the extent of surgery for early breastcancer on local recurrence ... type of mastectomy forbreastcancer treatment. Breast Cancer Res Treat 2006, 96:47-51.102. Gulben K, Yildirim E, Berberoglu U: Prediction of occult nipple-areolacomplex involvement in breast cancer...
... Agency for Researchon Cancer, Lyon, France 1996, 66:253-365.11. Swerdlow AJ, Jones ME: Tamoxifen treatment forbreastcancer and risk of endometrial cancer: a case-control study. J Natl Cancer ... feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989, 60(1):126-31.4. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM:Endometrial cancer in tamoxifen-treated ... eutic agent has led to its prophy-lactic use in the prevention ofbreastcancer in healthywomen at high risk of developing breastcancer and ithas also shown efficacy in this regard [9]. Despite...
... predictor of malignancy.Conclusion: Age ( 50) at the time of biopsy is an independent predictive factor forbreast cancer at surgical excision in patients with diagnosed ADH at CNB. Forpatients ... factor forbreastcancer at surgical excisionin patients with diagnosed ADH at CNB. Identification of patients with ADH diagnosed by CNB who can be sparedsurgical excision is an area of active ... performed on sus-picious breast lesions at the Seoul St. Mary's Hospital. Atotal of 69 CNBs led to a diagnosis of ADH, and 45 patients underwent follow-up surgical excision. Sevenpatients...
... M,Busch R, Molls M, Zimmermann FB: Longitudinal analysis of quality of lifein patients receiving conformal radiation therapy for prostate cancer. Strahlenther Onkol 2010, 186:46-52.17. Pinkawa ... Development andvalidation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men withprostate cancer. Urology 2000, 56:899-905.19. ... late effects have also been reported for prostate cancerpatients [12,13]. However, though qual-ity of life (QoL) issues are increasingly addressed in theliterature [14-17], the impact of acute...
... severity of acute breastcancer ther-apy-related morbidity is very limited. Breast- conserving therapy (BCT) is the accepted stan-dard treatment for early-stage breastcancer (BC) andconsists of ... treatment for BC should be performed inelderly women.IntroductionWith the aging of th e population, more older womenare being diagnosed with breast cancer. Over 40% of allnewly diagnosed breastcancer ... 5:103http://www.ro-journal.com/content/5/1/103Page 7 of 9 RESEARC H Open AccessIs standard breast- conserving therapy (BCT) inelderly breastcancerpatients justified? Aprospective measurement of acute toxicityaccording...